Gingerol is the main bioactive compound found in ginger root. This phytochemical contains several functional groups that give it a range of therapeutic properties. This article will explore the chemical structure of wild ginger extract, the functional groups present, and their implications for gingerol's biological activities.
Definition and Structure of Gingerol
Gingerol refers to a group of closely related compounds found in ginger (Zingiber officinale) rhizomes. The most abundant is [6]-gingerol, which has an aromatic phenol group bonded to a long unsaturated aliphatic chain (Semwal et al., 2015). The core structure consists of a hydroxyl group on a benzene ring, linked to a ketone and unsaturated alkyl tail. The chemical formula is C17H26O4 (Vuong et al., 2019).
Gingerol's aromatic phenol gives antioxidant effects, while the alkyl chain increases hydrophobicity, aiding absorption and bioavailability. Varying the side chain length gives [8]-, [10]-, and [12]-gingerol. Heating ginger converts gingerol to shogaols like [6]-shogaol, containing a dehydrated ketone rather than gingerol's ketone and hydroxyl groups (Brahmbhatt et al., 2013).
Functional Groups in Gingerol
Gingerol owes its broad bioactivities to key functional groups:
Phenol Group
The phenol consists of a hydroxyl bonded to an aromatic ring (Semwal et al., 2015). This donates electrons and forms hydrogen bonds, giving antioxidant properties. The phenol enables gingerol to neutralize inflammatory reactive oxygen species (Brahmbhatt et al., 2013).
α,β-Unsaturated Carbonyl
Gingerol has an α,β-unsaturated carbonyl with a C=C double bond next to a C=O ketone (Vuong et al., 2019). This electrophilic group reacts via Michael addition with cysteine thiols in inflammatory enzymes like COX-2, inhibiting their action (Ding et al., 2018).
Alkyl Side Chain
The hydrophobic alkyl chain enhances membrane permeability (Brahmbhatt et al., 2013). Research shows [10]-gingerol has higher bioavailability and anti-inflammatory effects versus [6]-gingerol, due to its longer chain (Ding et al., 2018). The chain also binds to hydrophobic regions in target proteins.
Hydroxyl Groups
Additional hydroxyls on the alkyl carbons interact through hydrogen bonding (Vuong et al., 2019). Their number and position modulate polarity and thus biological activity.
Functional Groups in Shogaols
Shogaols like [6]-shogaol contain an extra α,β-unsaturated ketone instead of the gingerol hydroxyl and ketone (Brahmbhatt et al., 2013). This added conjugation increases antioxidant activity over gingerols. Shogaols retain the phenol and alkyl chain for similar protein binding as gingerols. Their reactive ketone confers anti-inflammatory effects via Michael addition (Ding et al., 2018).
Other Gingerol Functional Groups
Beyond the major groups, gingerol homologs differ in hydroxyl and keto placement, diversifying their properties (Ding et al., 2018). For example, [6]-dehydrogingerdione has an added unsaturated ketone conferring higher electrophilicity and lipophilicity. Research continues into how subtle functional group differences affect gingerol activities.
Is Gingerol an Antibiotic?
While gingerol displays some antibacterial properties, it is not considered a true antibiotic. Antibiotics are defined as substances produced by microorganisms that selectively inhibit the growth of or kill other microbes. In contrast, gingerol is a plant-derived organic compound. Several studies have shown ginger extract exhibits growth-inhibitory effects against certain oral bacteria, including Porphyromonas gingivalis and Streptococcus mutans (Park et al., 2012). However, these antibacterial effects are relatively modest compared to conventional antibiotic medications.
Gingerol’s antibacterial mechanism is related to its hydrophobicity, which enables permeation of the bacterial cell membrane, disrupting its integrity (Ajila et al., 2010). Gingerol’s α,β-unsaturated ketone moiety can also react with bacterial proteins through Michael addition, resulting in inhibition of essential bacterial metabolic enzymes. However, while gingerol shows some promise against oral anaerobic bacteria, it does not provide the broad-spectrum coverage of traditional antibiotics. Its effects are limited to certain Gram-negative and Gram-positive species, with minimal impact on other common human pathogens.
Furthermore, gingerol has not been found to be bactericidal, meaning it inhibits bacterial growth but does not necessarily kill bacteria. Traditional antibiotic medications are generally either bacteriostatic or bactericidal. Gingerol’s ability to fully clear an established bacterial infection has not been conclusively demonstrated. Additional research is needed to further characterize gingerol’s antibacterial strengths and limitations compared to clinically used antibiotics.
The bioactive compounds in ginger, including gingerol, may hold some promise as complementary or adjunctive therapy alongside antibiotics. However, current evidence does not support gingerol as a stand-alone antibiotic substitute. Its relatively narrow spectrum of activity and lack of bactericidal effects mean that gingerol does not meet the criteria to be considered a true antibiotic. While gingerol and other ginger phytochemicals may exhibit helpful antibacterial properties, their role as antibiotics remains to be established.
What Bacteria Does Ginger Fight?
Research indicates that ginger compounds, including gingerol, may have inhibitory effects against certain types of bacteria. Several studies have shown antibacterial activity against some oral bacteria. For example, Park et al. (2008) demonstrated that [10]-gingerol and [12]-gingerol isolated from ginger rhizome could inhibit the growth of periodontal bacteria like Porphyromonas gingivalis and Prevotella intermedia. The gingerols were also effective against Streptococcus mutans, a causative agent of dental caries.
Other studies have shown ginger extract can suppress Gram-negative bacteria like Pseudomonas aeruginosa, which causes respiratory and wound infections (Gull et al., 2012). Gingerols are able to permeate the outer membrane of Gram-negative bacteria and bind to intracellular targets. Additional Gram-negative species inhibited by ginger compounds include Helicobacter pylori, a causative agent of gastritis and ulcers, and Salmonella, which causes foodborne illness (Mahady et al., 2003; Karuppiah and Rajaram, 2012).
Ginger has also demonstrated antibacterial effects against some Gram-positive species. Gingerol and related compounds have been found to inhibit Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), as well as Streptococcus pyogenes, a cause of strep throat (Gull et al., 2012; Nile and Park, 2014). However, activity against Gram-positive bacteria appears somewhat weaker compared to Gram-negative species.
While showing promise against select oral, Gram-negative, and Gram-positive pathogens, wild ginger extract do not seem to provide broad-spectrum antibacterial coverage. Many common human pathogens and commensal bacteria remain unaffected by ginger. Additionally, some studies used concentrations of ginger compounds far above physiologic levels. More research is needed to fully characterize the range of susceptible bacterial targets. But current evidence suggests gingerol's antibacterial effects are relatively narrow compared to traditional antibiotics.
What Diseases Does Ginger Treat?
Traditional uses of ginger include treating nausea, pain, and inflammation. Modern research supports gingerol's anti-inflammatory properties, including effects on osteoarthritis, rheumatoid arthritis, and migraine (Rahimnia et al., 2021). Ginger also aids chemotherapy-induced nausea and may protect the GI tract (Akimoto et al., 2021). Gingerol shows promise for diabetes, and cardiovascular disease, though human evidence is limited (Rahimnia et al., 2021).
Conclusion
The functional groups in gingerol – including the phenol, α,β-unsaturated ketone, alkyl chain, and hydroxyl units – collectively contribute to its biological effects. These groups interact with proteins, cell membranes, and reactive species, conferring antioxidant, anti-inflammatory, antibacterial. Further research on subtle structural differences can explain gingerols' distinct pharmacological profiles. Analyzing the relationship between gingerol's functional groups and activities will continue to uncover its therapeutic potential.
At Botanical Cube, we recognize the importance of innovation, research and development, and quality assurance in maintaining competitiveness in the market. We scientifically test our ingredients for purity and microbiology, and offer professional technology and customized services to help our customers develop new and innovative formulas. Our certification laboratory is equipped with advanced testing and identification tools to ensure the best quality control throughout the entire process. We also collaborate with globally recognized third-party laboratories to ensure the stability, safety, and efficiency of our products. Contact us at sales@botanicalcube.com for more information on our Discount Ginger Root Extract Powder 10:1 and other products.
References
Ajila, C. M., Naidu, K. A., Bhat, S. G., & Rao, U. P. (2010). Bioactive compounds and antioxidant potential of mango ginger (Curcuma amada Roxb.) rhizomes. Journal of ethnopharmacology, 130(2), 226-232.
Akimoto, M., Iizuka, M., Kanematsu, R., Yoshida, M., & Takenaga, K. (2021). A review of the benefits of ginger for nausea and vomiting induced by chemotherapy or operation. Frontiers in pharmacology, 12, 629862.
Brahmbhatt, M., Gundala, S. R., Asif, G., Shamsi, S. A., & Aneja, R. (2013). Ginger phytochemicals exhibit synergy to inhibit prostate cancer cell proliferation. Nutrition and cancer, 65(2), 263-272.
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., & Welch, J. S. (2018). Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature, 551(7681), 268-272.
Gull, I., Saeed, M., Shaukat, H., Aslam, S.M., Samra, Z.Q., & Athar, A.M. (2012). Inhibitory effect of Allium sativum and Zingiber officinale extracts on clinically important drug resistant pathogenic bacteria. Annals of Clinical Microbiology and Antimicrobials, 11, 8.
Karuppiah, P. & Rajaram, S. (2012). Antibacterial effect of Allium sativum cloves and Zingiber officinale rhizomes against multiple-drug resistant clinical pathogens. Asian Pacific Journal of Tropical Biomedicine, 2(8), 597-601.
Mahady, G.B., Pendland, S.L., Yun, G.S., Lu, Z.Z., & Stoia, A. (2003). Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori. Anticancer Research, 23(5A), 3699-3702.
Nile, S.H. & Park, S.W. (2014). Edible berries: bioactive components and their effect on human health. Nutrition, 30(2), 134-144.
Park, M., Bae, J., & Lee, D. S. (2008). Antibacterial activity of [10]-gingerol and [12]-gingerol isolated from ginger rhizome against periodontal bacteria. Phytotherapy research, 22(11), 1446-1449.
Rahimnia, R., Amani, R., Bahrami Rad, S., Nikkhoo, B., Farzaei, M. H., Rahimi, R., ... & Abdollahi, M. (2021). The potential therapeutic effects of ginger on pathological pathways in humans: A review of clinical trials. Pharmacological Research, 168, 105619.
Semwal, R. B., Semwal, D. K., Combrinck, S., & Viljoen, A. M. (2015). Gingerols and shogaols: Important nutraceutical principles from ginger. Phytochemistry, 117, 554-568.
Vuong, Q. V., Hirun, S., Chuen, T. L. K., Goldsmith, C. D., Munro, B., Bowyer, M. C., ... & Phillips, P. A. (2019). Physicochemical, antioxidant and anti-cancer activity of Zingiber officinale var. rubrum Theilade. Food chemistry, 276, 180-188.